Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
Clinical trial NCT03257995 · COMPLETED
Trial details
- NCT number
- NCT03257995
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2018-01-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.